TY - JOUR AU - Mole, R. H. PY - 1953 DA - 1953// TI - Whole body irradiation; radiobiology or medicine? JO - Br J Radiol VL - 26 UR - https://doi.org/10.1259/0007-1285-26-305-234 DO - 10.1259/0007-1285-26-305-234 ID - Mole1953 ER - TY - JOUR AU - Formenti, S. C. AU - Demaria, S. PY - 2009 DA - 2009// TI - Systemic effects of local radiotherapy JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(09)70082-8 DO - 10.1016/S1470-2045(09)70082-8 ID - Formenti2009 ER - TY - STD TI - Borghaei H, Brahmer JR, Horn L, et al. Nivolumab (nivo) vs docetaxel (doc) in patients (pts) with advanced NSCLC: CheckMate 017/057 2-y update and exploratory cytokine profile analyses. J Clin Oncol. 2016;34(15_suppl):9025–25. ID - ref3 ER - TY - JOUR AU - Reynders, K. AU - Illidge, T. AU - Siva, S. PY - 2015 DA - 2015// TI - The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant JO - Cancer Treat Rev VL - 41 UR - https://doi.org/10.1016/j.ctrv.2015.03.011 DO - 10.1016/j.ctrv.2015.03.011 ID - Reynders2015 ER - TY - JOUR AU - Koller, K. M. AU - Mackley, H. B. AU - Liu, J. PY - 2017 DA - 2017// TI - Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone JO - Cancer Biol Ther VL - 18 UR - https://doi.org/10.1080/15384047.2016.1264543 DO - 10.1080/15384047.2016.1264543 ID - Koller2017 ER - TY - JOUR AU - Aboudaram, A. AU - Modesto, A. AU - Chaltiel, L. PY - 2017 DA - 2017// TI - Concurrent radiotherapy for patients with metastatic melanoma and receiving anti-programmed-death 1 therapy: a safe and effective combination JO - Melanoma Res VL - 27 UR - https://doi.org/10.1097/CMR.0000000000000386 DO - 10.1097/CMR.0000000000000386 ID - Aboudaram2017 ER - TY - JOUR AU - Zhang, X. AU - Niedermann, G. PY - 2018 DA - 2018// TI - Abscopal effects with Hypofractionated schedules extending into the effector phase of the tumor-specific T-cell response JO - Int J Radiat Oncol Biol Phys VL - 101 UR - https://doi.org/10.1016/j.ijrobp.2018.01.094 DO - 10.1016/j.ijrobp.2018.01.094 ID - Zhang2018 ER - TY - JOUR AU - Cong, Y. AU - Shen, G. AU - Wu, S. AU - Hao, R. PY - 2017 DA - 2017// TI - Abscopal regression following SABR for non-small-cell-lung cancer: a case report JO - Cancer Biol Ther VL - 18 UR - https://doi.org/10.1080/15384047.2016.1264541 DO - 10.1080/15384047.2016.1264541 ID - Cong2017 ER - TY - JOUR AU - Golden, E. B. AU - Demaria, S. AU - Schiff, P. B. PY - 2013 DA - 2013// TI - An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer JO - Cancer Immunol Res VL - 1 UR - https://doi.org/10.1158/2326-6066.CIR-13-0115 DO - 10.1158/2326-6066.CIR-13-0115 ID - Golden2013 ER - TY - STD TI - Antonia SJ, Villegas A, Daniel D, et al. Durvalumab after Chemoradiotherapy in stage III non-small-cell lung Cancer. N Engl J Med. 2017;377:1919–29. ID - ref10 ER -